| scholarly article | Q13442814 |
| P50 | author | Sophie Paczesny | Q56479795 |
| P2093 | author name string | Thomas Braun | |
| Joel Whitfield | |||
| James L M Ferrara | |||
| John E Levine | |||
| Sung W Choi | |||
| Gregory Yanik | |||
| Raymond J Hutchinson | |||
| Dawn Jones | |||
| Carrie L Kitko | |||
| P2860 | cites work | Pathophysiologic mechanisms of acute graft-vs.-host disease | Q33793177 |
| Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia | Q33857573 | ||
| The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation | Q33898254 | ||
| In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets | Q35847952 | ||
| Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity | Q35900973 | ||
| The pathophysiology of tumor necrosis factors | Q36135208 | ||
| Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia? | Q36152695 | ||
| Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease | Q36357597 | ||
| Pathophysiology of graft-versus-host disease | Q36368101 | ||
| Immunogenomics of unrelated hematopoietic cell transplantation | Q36548014 | ||
| Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease | Q36615576 | ||
| Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease | Q37388077 | ||
| A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment | Q42097784 | ||
| Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems | Q44097093 | ||
| Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. | Q45048826 | ||
| Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. | Q45245159 | ||
| Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia | Q45864372 | ||
| Two tumour necrosis factor receptors: structure and function. | Q49167492 | ||
| Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. | Q53596074 | ||
| A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood | Q57515100 | ||
| Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin | Q58618269 | ||
| Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes | Q59315421 | ||
| Allogeneic Stem Cell Transplantation in First Complete Remission Enhances Graft-versus-Leukemia Effect in Adults with Acute Lymphoblastic Leukemia: Antileukemic Activity of Chronic Graft-versus-Host Disease | Q62022718 | ||
| Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F | Q66829418 | ||
| Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease | Q68140704 | ||
| Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation | Q68193951 | ||
| Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation | Q68928908 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children | Q70200026 | ||
| Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation | Q70582290 | ||
| Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of | Q71911659 | ||
| Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing | Q73451177 | ||
| Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines | Q73894705 | ||
| Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation | Q78494858 | ||
| Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation | Q80177840 | ||
| The incidence and risk factors for chronic graft-versus-host-disease | Q80311320 | ||
| Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation | Q94448371 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 759-765 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients | |
| P478 | volume | 14 |
| Q35083894 | Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. |
| Q27021123 | Advances in predicting acute GVHD |
| Q39425522 | Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II-IV acute GvHD: a systematic review and meta-analysis |
| Q91254526 | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation |
| Q61811647 | Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation |
| Q36821646 | Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial |
| Q88573546 | Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis |
| Q43198292 | Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning |
| Q34093615 | Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation |
| Q37262519 | Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality |
| Q36370782 | Implications of TNF-α in the pathogenesis and management of GVHD |
| Q35848391 | Mesenchymal stromal cells: a new tool against graft-versus-host disease? |
| Q38381708 | Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide |
| Q38038568 | Potential biomarkers for early detection of acute graft-versus-host disease |
| Q90290687 | Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer |
| Q38829335 | The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review |
| Q55386131 | Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology. |
Search more.